(Q47224121)

12 January 2018

title

Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study (English)

1 reference

12 January 2018

1 reference

Ganoderma lucidum

1 reference

3

1 reference

12 January 2018

author name string

Sissi Wachtel-Galor

series ordinal

1

1 reference

12 January 2018

Brian Tomlinson

series ordinal

2

1 reference

12 January 2018

publication date

1 February 2004

1 reference

12 January 2018

British Journal of Nutrition

published in

1 reference

12 January 2018

volume

91

1 reference

12 January 2018

issue

2

1 reference

12 January 2018

page(s)

263-269

1 reference

12 January 2018

Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs.

cites work

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Biodegradative and biosynthetic capacities of mushrooms: present and future strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Evaluation of serum and tissue levels of alpha-tocopherol

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Mushrooms, tumors, and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Ganoderma lucidum ('Lingzhi'); acute and short-term biomarker response to supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Unconventional medicine in the United States. Prevalence, costs, and patterns of use

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Effects of dietary antioxidants on human DNA ex vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Improved analysis of malondialdehyde in human body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

A ganoderic acid derivative, a highly oxygenated lanostane-type triterpenoid from Ganoderma lucidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN20041039

21 January 2018

Identifiers

DOI

10.1079/BJN20041039

1 reference

12 January 2018

1 reference

12 January 2018